• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    G

    Générale de Santé

    EST. 1987
    179论文总数
    887引用总数

    论文量&引用量时间轴

    机构学者

    论文(179)

    年份
    起
    –
    止
    排序
    1Update of Guidelines for Management of Community Acquired Pneumonia in Adults by the French Infectious Disease Society (SPILF) and the French-Speaking Society of Respiratory Diseases (SPLF).
    Aurélien Dinh,François Barbier,Jean-Pierre Bedos,Mathieu Blot,Vincent Cattoir,Yann-Erick Claessens,Xavier Duval, Pierre Fillâtre, Maxime Gautier, Yann Guegan,Sophie Jarraud,Alban Le Monnier,
    2025Respiratory Medicine and Research(2025)引用:4
    引用
    AI阅读
    加入学术空间
    2EndoscopX: French Review of Radiation Protection in Endoscopy
    L Koch-Marquant, C Jean-Baptiste, S Leblanc, G Hossu, L Caillo,P Mayer, T Degand, V Geoffroy, S Koch,B Brieau, B Girard, J L Basile,
    2025Endoscopy ESGE Days 2025(2025)
    引用
    AI阅读
    加入学术空间
    3Assessing Circadian Rhythms and Chemotherapy Safety in Remote Patients with Pancreatic Ductal Adenocarcinoma (PDAC) Using a Multidimensional Digital Platform (multidom, NCT04263948).
    Francis Albert Levi,Ayhan Ulusakarya,Sandrine Dulong, Rachel Bossevot, Dounya Boudriche, Xiaomei Li, Imene Hadj-Naceur, Elise Colle, Claudia Viaro, Tambo Bathily, Anne Thirot-Bidault, Pascal Agranat,

    1650 Background: The disruption of circadian clocks is associated with reduced survival and treatment tolerability in cancer patients (pts). Here, real-time analyses of telemonitored circadian rhythms and electronic Pt-Reported Outcome (ePRO) are integrated within a multidimensional telemonitoring-telecare digital platform that triggers proactive telecare toward improved quality of life (QoL) and treatment safety. Methods: The multicentre, interventional, prospective, longitudinal, single-arm study recruited pts receiving mFOLFIRINOX chemotherapy (CT) q2-weeks for pancreatic ductal adenocarcinoma (PDAC). Early warning signals of circadian disruption, body weight loss, and ePROs severity are extracted from real time analysis and graphical displays of (i) continuously telemonitored rest-activity and chest surface temperature (chestemp) rhythms using a chest sensor, and (ii) daily body weight (e-balance), and (iii) daily self-rating of 23 symptoms using a GPRS tablet (MD Anderson Symptoms Inventory, MDASI). Pts participate for 1 week before (baseline) and 6 weeks after 1 st CT course. Circadian disruption is defined by an (I < O) value < 96%. (I < O) is the % accelerations per min In-Bed that are below median accelerations per min Out-of-Bed for 3 days; (I < O) range in controls, 97-100%). Automatic alerts are sent via internet for decision of proactive intervention by the oncology team, in case of circadian disruption, chestemp increase by 1.5°C, weight loss > 5%, or MDASI symptom ≥ 7. Results: From 6/2021 to 7/2024, 58 pts with advanced PDAC were selected (male, 52%), median age, 58 y.o. (range, 33-82); WHO performance status (PS) 0/1/2, 36%/53%/10% of the pts; metastatic sites 0/1/ > 2, 38%/24%/8%; liver metastases, 50%). Early PDAC-related complications prevented platform use in 5 pts. The platform was used by 53 pts during a median of 45.5 days (IQR, 38-50], with > 85% compliance. At baseline, large between-pts differences in circadian rhythms were found for both rest-activity I < O (median [IQR]), 98.4 accelerations/min [95.8-99.6]); range, 75 to 100), and chestemp circadian amplitude (median, 1.1°C [IQR, 0.7-1.4], range, 0.3°C to 2.7°C). Baseline circadian disruption was larger in male pts (56% vs 31%; p = 0.07) and in those with PS 1-2 (47% vs 14%; p = 0.02). Consistently, median chestemp circadian amplitude was less in males compared to females (0.8°C vs 1.3°C, p < 0.01) and in pts with PS = 1-2 compared to PS = 0 (0.8°C vs 1.3°C; p < 0.01). Maximum toxicities of CT were circadian disruption (100% of the pts), body weight loss > 5% (59%), and MDASI symptom ≥7 (46%), without any influence of baseline pt characteristics. Conclusions: The use of this multidimensional digital platform combining circadian and other physiology metrics with ePROs was feasible and accepted by the pts. Its implementation seemed to be clinically relevant toward improving the care of remote pts at risk of adverse events. Clinical trial information : 04263948.

    2025JOURNAL OF CLINICAL ONCOLOGY(2025)
    引用
    AI阅读
    加入学术空间
    4Remettre En Mouvement Les Corps De Personnes Atteintes D’obésité Via La Collaboration Pluriprofessionnelle
    Saïqa Ghulam, Candice Giacomino, Sarah Bozec
    2025Soins(2025)
    引用
    AI阅读
    加入学术空间
    5Assisted Peritoneal Dialysis in France Threatened by Restrictive Interpretation of Legislation by CPAM?
    Guy Rostoker,Belkacem Issad, Joelle Pittion-Marin, Hafedh Fessi

    France has been a pioneer in the implementation of assisted peritoneal dialysis (PD), with its first institutional programs launched in the late 1970s. According to data from the French-language Peritoneal Dialysis Registry (RDPLF), approximately a third of patients treated by PD receive assistance, placing France among the european and OECD countries with the highest proportion of assisted peritoneal dialysis. Assisted PD is recommended by european and international guidelines, which are based on the french model. A recent incident at the Bouchard Clinic in Marseille highlights the current administrative challenges associated with peritoneal dialysis assisted by private nurses. It also underscores the potential risks of a restrictive interpretation of administrative policies by certain primary health insurance funds. It is vital that the medical and cultural achievement of assisted peritoneal dialysis be defended. On October 6, 2025, the events in Marseille led stakeholders from the nephrology community, the nursing world, patient associations and hospital federations to write a joint letter of alert to the Director of Healthcare Provision at the French Ministry of Health on this issue.

    2025Bulletin de la Dialyse à Domicile(2025)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 179 篇论文

    合作机构(100)

    巴黎医院公共援助合作论文 10
    艾克斯 - 马赛大学合作论文 6
    里昂市民临终关怀院合作论文 6
    巴黎第三大学合作论文 4
    Foederatio Medicorum Helveticorum合作论文 4
    格勒诺布尔 - 阿尔卑斯大学合作论文 4
    Hôpital Cochin,Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale,Assistance Publique – Hôpitaux de Paris合作论文 4
    Institut de Veille Sanitaire合作论文 4
    法国国家健康与医学研究院合作论文 4
    波尔多大学合作论文 3

    机构统计